SignalHF Development and clinical evaluation of an end-to-end Heart Failure management solution powered by predictive AI
- Coordinator
- Implicity, France
- Runs
- 1 May 2025 to 30 April 2027
- Status
- Running
- EU funding
- €2.5m
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 101188592
What the project is doing
In the project's own words, from its summary on CORDIS.
Heart failure is a serious chronic medical condition that impairs the heart’s ability to effectively pump blood. Globally, it has a prevalence of 64 million people. Heart failure patients often have to be hospitalised to manage symptoms exacerbation. These hospitalisations are preventable with data-based insights and tailored therapies. But no holistic data platform for heart failure patients exists today. Implicity is set to change this situation with its suite of data-driven insights for managing heart failure.
Implicity already provides a heart failure remote monitoring platform with symptoms-based decompensation detection features. In this project, we are developing a second module that focuses on AI-based prediction of heart failure events based on cardiac implantable electronic devices’ data, combined with an end-to-end software suite managing alerts, treatments, patient engagement and workflow optimisation, enabling better care and decreasing the hospitalisation burden.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Implicity | Paris | France | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI